Pulmatrix (PULM) Debt Ratio (2014 - 2018)

Pulmatrix (PULM) posted Debt Ratio of 0.18 for Q1 2018, down 8.77% sequentially from 0.2 in Q4 2017, and down 19.12% YoY from 0.23 in Q1 2017.

Pulmatrix (PULM) Debt Ratio (2014 - 2018) Analysis & Trends

Pulmatrix has reported Debt Ratio for 5 years, with the latest figure at 0.18 in Q1 2018.

Quarterly Debt Ratio fell 19.12% year-over-year to 0.18 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was 0.18 (down 19.12% YoY) and the FY2017 annual result came in at 0.2, down 42.11% from the prior year.
Debt Ratio declined to 0.18 in Q1 2018 per PULM's latest filing, from 0.2 in the prior quarter.
Over five years, Debt Ratio peaked at 0.35 in Q4 2016 and troughed at 0.0 in Q3 2014.
A 5-year average of 0.15 and a median of 0.18 in 2018 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2015 and 2017: Debt Ratio soared 93556.56% in 2015, then sank 42.11% in 2017.
Over 5 years, Debt Ratio stood at 0.0 in 2014, then jumped by 23130.61% to 0.15 in 2015, then surged by 132.51% to 0.35 in 2016, then tumbled by 42.11% to 0.2 in 2017, then declined by 8.77% to 0.18 in 2018.
According to Business Quant data, Debt Ratio over the past three periods registered 0.18, 0.2, and 0.2 for Q1 2018, Q4 2017, and Q3 2017 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.96 Bn	132.11 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.79 Bn	78.79 Bn	3.93 Bn	0.05
3	Argenx Se	65.22 Bn	60.03 Bn	1.37 Bn	-
4	Moderna	60.20 Bn	55.06 Bn	52.00 Mn	0.05
5	BeOne Medicines	42.19 Bn	37.09 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.43 Bn	28.12 Bn	992.69 Mn	-
7	BioNTech SE	28.65 Bn	10.26 Bn	668.28 Mn	0.03
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.16 Bn	26.32 Bn	-	0.47
10	Pulmatrix	5.55 Mn	5.55 Mn	-	-

Download Data